The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.

Dr. Ulrich Betz, Vice President Innovation; Department Head Future Insight, Merck KGaA; Department Head Innovation & Entrepreneurship Incubator, Merck Healthcare KGaA

Dr. Siegfried Bialojan, Executive Director, Head Life Science Center, Ernst & Young GmbH, Mannheim

Dr. Elmar Bourdon, Manager of Medical Technology Cluster, City of Mannheim

Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)

Dr. Adrian J. Carter, Corporate Vice President of Discovery Research Coordination, Boehringer Ingelheim International GmbH, Ingelheim am Rhein

Dr. Jürgen Gamer, VP Business Development Apogenix AG, Heidelberg

Dr. Jan Gradel, Director Business Development Sino German Hi Tech Park Holding GmbH, Heidelberg

Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim

Thomas Hegendoerfer, New Ventures Lead in Germany for Johnson & Johnson Innovation, Neuss

Dr. Andreas Kempff, Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg

Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main

Dr. Joerg Rauch, Managing Director, technology transfer Heidelberg GmbH

Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg

Dr. Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg

Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main

The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects

Dr. Christof Antz, Velabs Therapeuticals GmbH, Heidelberg

Dr. Juergen Bauer, Deputy Managing Director, Head of Business Development, EMBLEM Technology Transfer GmbH, Heidelberg

PD Dr. Gerard Drewes, Head of Science, Cellzome GmbH – a GSK company, Heidelberg

Prof. Dr. Mathias Hafner (Chair), Director of the Institute for Molecular and Cell Biology, Mannheim University of Applied Sciences

Prof. Dr. Alfred Hahn, Head of Discovery, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen

Prof. Dr. Klaus Heeg, Deputy Managing Director of the Center of Infection Diseases, Microbiologies and Hygiene, University Hospital Heidelberg

Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg

Dr. Thomas Pultar, CEO, BIOMEVA GmbH, Heidelberg

Dr. Friedrich Rippmann, Director, Global Computational Chemistry Merck KGaA, Darmstadt

Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg